Multiple Myeloma Drugs Market Report by Therapy (Targeted Therapy, Biologic Therapy, Chemotherapy, and Others), Drug Type (Immunomodulatory Drugs, Proteasome Inhibitors, Histone Deacetylase Inhibitors, Monoclonal Antibody Drugs, Steroids, and Others), End-User (Men, Women), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2169

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Pipeline Assesment/Clinical Trial Products/Clinical Developments
5.1 PegIntron (Pegylated interferon alfa-2b)
5.2 Pomalidomide
5.3 Tanespimycin (KOS-953)
5.4 MLN 9708
5.5 SRT-501- 012
5.6 BHQ880
5.7 Panobinostat
5.8 ZIO-101
5.9 VEGF-Trap(Aflibercept)
5.10 Denosumab
5.11 Perifosine
5.12 Actimid (CC-5013)
5.13 Romidepsin
5.14 Plitidepsin (Aplidin)
5.15 Temsirolimus (Torisel)
5.16 Sorafenib
5.17 Bevacizumab
6 Global Multiple Myeloma Drugs Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Forecast
7 Market Breakup by Therapy
7.1 Targeted Therapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biologic Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Chemotherapy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Drug Type
8.1 Immunomodulatory Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Proteasome Inhibitors
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Histone Deacetylase Inhibitors
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Monoclonal Antibody Drugs
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Steroids
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End-User
9.1 Men
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Women
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Amgen Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Bristol Myers Squibb
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Daiichi Sankyo Co.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Sanofi-Aventis Groupe (Genzyme Corporation)
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 SWOT Analysis
16.3.5 Johnson & Johnson Services, Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck & Co., Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Novartis International AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Pfizer Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 PHARMA MAR, S.A.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Takeda Pharmaceutical Company Limited.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Teva Pharmaceutical Industries Ltd.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Multiple Myeloma Drugs Market: Major Drivers and Challenges
Figure 2: Global: Multiple Myeloma Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Multiple Myeloma Drugs Market: Breakup by Therapy (in %), 2024
Figure 4: Global: Multiple Myeloma Drugs Market: Breakup by Drug Type (in %), 2024
Figure 5: Global: Multiple Myeloma Drugs Market: Breakup by End-User (in %), 2024
Figure 6: Global: Multiple Myeloma Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Multiple Myeloma Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Multiple Myeloma Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Multiple Myeloma Drugs (Targeted Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Multiple Myeloma Drugs (Targeted Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Multiple Myeloma Drugs (Biologic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Multiple Myeloma Drugs (Biologic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Multiple Myeloma Drugs (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Multiple Myeloma Drugs (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Multiple Myeloma Drugs (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Multiple Myeloma Drugs (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Multiple Myeloma Drugs (Immunomodulatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Multiple Myeloma Drugs (Immunomodulatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Multiple Myeloma Drugs (Proteasome Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Multiple Myeloma Drugs (Proteasome Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Multiple Myeloma Drugs (Histone Deacetylase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Multiple Myeloma Drugs (Histone Deacetylase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Multiple Myeloma Drugs (Monoclonal Antibody Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Multiple Myeloma Drugs (Monoclonal Antibody Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Multiple Myeloma Drugs (Steroids) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Multiple Myeloma Drugs (Steroids) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Multiple Myeloma Drugs (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Multiple Myeloma Drugs (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Multiple Myeloma Drugs (Men) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Multiple Myeloma Drugs (Men) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Multiple Myeloma Drugs (Women) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Multiple Myeloma Drugs (Women) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Multiple Myeloma Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Multiple Myeloma Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Multiple Myeloma Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Multiple Myeloma Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Multiple Myeloma Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Multiple Myeloma Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Multiple Myeloma Drugs (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Multiple Myeloma Drugs (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: North America: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: North America: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Canada: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Canada: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Asia Pacific: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Asia Pacific: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: China: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: China: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Japan: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Japan: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: India: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: India: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: South Korea: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: South Korea: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Australia: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Australia: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Indonesia: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Indonesia: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Europe: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Europe: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Germany: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Germany: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: France: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: France: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: United Kingdom: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: United Kingdom: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Italy: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Italy: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Spain: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Spain: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Russia: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Russia: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Latin America: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Latin America: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Brazil: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Brazil: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Mexico: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Mexico: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Others: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Others: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Middle East and Africa: Multiple Myeloma Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Middle East and Africa: Multiple Myeloma Drugs Market: Breakup by Country (in %), 2024
Figure 89: Middle East and Africa: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Global: Multiple Myeloma Drugs Industry: SWOT Analysis
Figure 91: Global: Multiple Myeloma Drugs Industry: Value Chain Analysis
Figure 92: Global: Multiple Myeloma Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Multiple Myeloma Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Therapy (in Million USD), 2025-2033
Table 3: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 4: Global: Multiple Myeloma Drugs Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 5: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Multiple Myeloma Drugs Market Structure
Table 8: Global: Multiple Myeloma Drugs Market: Key Players

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.

Multiple Myeloma Drugs Market

Purchase Options DiscountOffer